Trastuzumab in Treating Women With HER2-Positive Early Breast Cancer

NCT00712140 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

4000

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: trastuzumab
DRUG: parenteral chemotherapy

Sponsor

Warwick Medical School